These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 32980616)

  • 1. Update, validation and comparison of three different clinicopathological scores for patients with resected gastric cancer: A western experience.
    Díaz Del Arco C; Estrada Muñoz L; Ortega Medina L; Chávez Á; Ruiz Adelantado I; García Gómez de Las Heras S; Fernández Aceñero MJ
    Ann Diagn Pathol; 2020 Dec; 49():151635. PubMed ID: 32980616
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Towards standardization of lymph-node ratio classifications: Validation and comparison of different lymph node ratio classifications for predicting prognosis of patients with resected gastric cancer.
    Díaz Del Arco C; Estrada Muñoz L; Sánchez Pernaute A; Ortega Medina L; García Gómez de Las Heras S; García Martínez R; Fernández Aceñero MJ
    Ann Diagn Pathol; 2021 Jun; 52():151738. PubMed ID: 33865185
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Development of a simplified tumor-lymph node ratio classification system for patients with resected gastric cancer: A western study.
    Díaz Del Arco C; Estrada Muñoz L; Sánchez Pernaute A; Ortega Medina L; García Gómez de Las Heras S; García Martínez R; Fernández Aceñero MJ
    Ann Diagn Pathol; 2021 Feb; 50():151677. PubMed ID: 33310591
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Which Lymph Node Staging System Better Predicts Prognosis in Patients With Gastric Carcinoma? A Comparative Study Between 3 Different Lymph Node Classifications for Resected Gastric Cancer in a Western Tertiary Center.
    Díaz Del Arco C; Estrada Muñoz L; Sánchez Pernaute A; Ortega Medina L; García Gómez de Las Heras S; García Martínez R; Fernández Aceñero MJ
    Am J Clin Oncol; 2021 Jan; 44(1):1-9. PubMed ID: 33086233
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Proposal for a clinicopathological prognostic score for resected gastric cancer patients.
    DIaz Del Arco C; Estrada Muñoz L; Molina Roldán E; Ortega Medina L; García Gómez de Las Heras S; Chávez Á; Fernández Aceñero M
    Saudi J Gastroenterol; 2021; 27(1):44-53. PubMed ID: 33047677
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The log odds of negative lymph nodes/T stage: a new prognostic and predictive tool for resected gastric cancer patients.
    Xie J; Pang Y; Li X; Wu X
    J Cancer Res Clin Oncol; 2021 Aug; 147(8):2259-2269. PubMed ID: 34003367
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinicopathological differences, risk factors and prognostic scores for western patients with intestinal and diffuse-type gastric cancer.
    Díaz Del Arco C; Estrada Muñoz L; Ortega Medina L; Molina Roldán E; Cerón Nieto MÁ; García Gómez de Las Heras S; Fernández Aceñero MJ
    World J Gastrointest Oncol; 2022 Jun; 14(6):1162-1174. PubMed ID: 35949214
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Topographic lymph node staging system shows prognostic superiority compared to the 8th edition of AJCC TNM in gastric cancer. A western monocentric experience.
    Lauricella S; Caricato M; Mascianà G; Carannante F; Carnazza M; Bonaccorso A; Angeletti S; Ciccozzi M; Coppola R; Capolupo GT
    Surg Oncol; 2020 Sep; 34():223-233. PubMed ID: 32869748
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prognostic factors and outcomes in Italian patients undergoing curative gastric cancer surgery.
    Posteraro B; Persiani R; Dall'Armi V; Biondi A; Arzani D; Sicoli F; Bonassi S; D'Ugo D; Ricciardi W; Boccia S
    Eur J Surg Oncol; 2014 Mar; 40(3):345-51. PubMed ID: 24268760
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prognostic impact of Borrmann classification on advanced gastric cancer: a retrospective cohort from a single institution in western China.
    Song XH; Zhang WH; Kai-Liu ; Chen XL; Zhao LY; Chen XZ; Kun-Yang ; Zhou ZG; Hu JK
    World J Surg Oncol; 2020 Aug; 18(1):204. PubMed ID: 32792016
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prognostic Model Based on Systemic Inflammatory Response and Clinicopathological Factors to Predict Outcome of Patients with Node-Negative Gastric Cancer.
    Qu JL; Qu XJ; Li Z; Zhang JD; Liu J; Teng YE; Jin B; Zhao MF; Yu P; Shi J; Fu LY; Wang ZN; Liu YP
    PLoS One; 2015; 10(6):e0128540. PubMed ID: 26075713
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Clinicopathological features and survival analysis of gastric cancer patients with neuroendocrine differentiation after radical resection].
    Yu S; Lyu MZ; Luo RK; Liu FL; Liu TS
    Zhonghua Wei Chang Wai Ke Za Zhi; 2021 May; 24(5):426-432. PubMed ID: 34000772
    [No Abstract]   [Full Text] [Related]  

  • 13. Presence of cancer cells in gastric lavage of gastric cancer patients as an indicator of advanced disease, predictor of tumour aggressive phenotype and independent prognostic factor for poor survival: The endoluminal metastatic pathway of gastric cancer and GL0/GL1 classification.
    Virgilio E; Giarnieri E; Giovagnoli MR; Montagnini M; Proietti A; D'Urso R; Nigri G; Mercantini P; Ramacciato G; Cavallini M; Balducci G
    Cytopathology; 2018 Feb; 29(1):41-48. PubMed ID: 29063636
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The prognostic value of different node staging systems in patients with ≤15 lymph nodes following surgery for gastric adenocarcinoma.
    Kılıç MÖ; Gündoğdu SB; Özden S; Saylam B; Tez M
    Acta Chir Belg; 2018 Feb; 118(1):1-6. PubMed ID: 28669280
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prealbumin and lymphocyte-based prognostic score, a new tool for predicting long-term survival after curative resection of stage II/III gastric cancer.
    Shen Q; Liu W; Quan H; Pan S; Li S; Zhou T; Ouyang Y; Xiao H
    Br J Nutr; 2018 Dec; 120(12):1359-1369. PubMed ID: 30370885
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Using the preoperative prognostic nutritional index as a predictive factor for non-cancer-related death in post-curative resection gastric cancer patients: a retrospective cohort study.
    Takechi H; Fujikuni N; Tanabe K; Hattori M; Amano H; Noriyuki T; Nakahara M
    BMC Gastroenterol; 2020 Aug; 20(1):256. PubMed ID: 32758144
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Fibroblast growth factor receptor 4 protein expression and clinicopathological features in gastric cancer.
    Chen H; Shen DP; Zhang ZZ; Liu JH; Shen YY; Ni XZ
    World J Gastroenterol; 2015 Feb; 21(6):1838-44. PubMed ID: 25684949
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Comparison of clinicopathological features and prognosis analysis between carcinoma in the remnant stomach and gastric cancer].
    Li F; Wang Y; Li C; Ma Y; Zhang Y; Li Z; Xue Y
    Zhonghua Wei Chang Wai Ke Za Zhi; 2018 May; 21(5):529-534. PubMed ID: 29774934
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Comparison of clinicopathological features and prognosis between adenocarcinoma of esophagogastric junction and adenocarcinoma of gastric antrum].
    Zhu Z; Wang Y; Li F; Gao J; Han B; Wang R; Xue Y
    Zhonghua Wei Chang Wai Ke Za Zhi; 2019 Feb; 22(2):149-155. PubMed ID: 30799537
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prognostic importance of RASSF2 expression in patients with gastric cancer who had undergone radical gastrectomy.
    Aydin D; Bilici A; Kayahan S; Yavuzer D; Basar M; Aliustaoglu M
    Clin Transl Oncol; 2016 Jun; 18(6):608-16. PubMed ID: 26459248
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.